Skip to main content
Telesis Bio, Inc. (TBIO)
NASDAQ: TBIO · IEX Real-Time Price · USD
4.000
-0.190 (-4.53%)
At close: Jul 19, 2024, 4:00 PM
4.010
+0.010 (0.25%)
Pre-market: Jul 22, 2024, 4:24 AM EDT

Telesis Bio Revenue

Telesis Bio had revenue of $24.63M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $3.44M. In the year 2023, Telesis Bio had annual revenue of $27.51M with 0.27% growth.

Revenue (ttm)
$24.63M
Revenue Growth
-12.38%
P/S Ratio
0.27
Revenue / Employee
$167,571
Employees
147
Market Cap
6.69M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202327.51M74.00K0.27%
Dec 31, 202227.44M16.39M148.44%
Dec 31, 202111.04M4.47M67.93%
Dec 31, 20206.58M1.77M36.86%
Dec 31, 20194.81M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareMax 810.36M
Sunshine Biopharma 26.74M
ReShape Lifesciences 8.34M
Xenetic Biosciences 2.44M
Alaunos Therapeutics 5.00K
Revenue Rankings

TBIO News

More News